Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Radiotherapy With or Without Cisplatin for Surgically Resected SCCHN
NCT02734537Phase 2Recruiting
- Sponsor
- ECOG-ACRIN Cancer Research Group
- Start
- Nov 2016
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Cisplatin micelle injection (HA132) in squamous cell carcinoma of the head and neck (HNSCC), sponsored by ECOG-ACRIN Cancer Research Group. Started Nov 2016; status: recruiting.
02
Drugs
Cisplatin micelle injection (HA132)
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT02734537.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02734537.